Cleared Traditional

K790017 - SERUM

K790017 is the FDA 510(k) clearance for SERUM by Fisher Scientific Co., LLC. It is a Class 2 Chemistry device (product code CIT) cleared through the Traditional 510(k) pathway after a 54-day FDA review.

K790017 · Fisher Scientific Co., LLC · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1979
Decision
54d
Days
Class 2
Risk

K790017 is an FDA 510(k) clearance for the SERUM, GLUTAMIC-OXALOACETIC. Classified as Nadh Oxidation/nad Reduction, Ast/sgot (product code CIT), Class II - Special Controls.

Submitted by Fisher Scientific Co., LLC (Mchenry, US). The FDA issued a Cleared decision on February 26, 1979 after a review of 54 days - a notably fast clearance cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1100 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Fisher Scientific Co., LLC devices

Submission Details

510(k) Number K790017 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 03, 1979
Decision Date February 26, 1979
Days to Decision 54 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
34d faster than avg
Panel avg: 88d · This submission: 54d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CIT Nadh Oxidation/nad Reduction, Ast/sgot
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1100
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CIT Nadh Oxidation/nad Reduction, Ast/sgot

All 104
Devices cleared under the same product code (CIT) and FDA review panel - the closest regulatory comparables to K790017.
PLUS CHEM S.C.E. REAGENT
K791080 · Smithkline Diagnostics, Inc. · Jul 1979
SPIN CHEM REAGENT, DETERMINATION OF AST
K791082 · Smithkline Diagnostics, Inc. · Jul 1979
COULTER ACCU-ZYME II GOT REAGENT
K790483 · Coulter Electronics, Inc. · May 1979
AST
K781784 · Gilford Diagnostics · Jan 1979
REAGENT SET, U.V. ENZMATIC KINETIC, SGOT
K781725 · Medical Analysis Systems, Inc. · Nov 1978
SINGLE VIAL 10 SGOT-TRIS
K780634 · Boehringer Mannheim Corp. · May 1978